Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Hamashima C. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2018;48:673–83. https://doi.org/10.1093/jjco/hyy077.

Article  PubMed  Google Scholar 

Kim T-H, Kim I-H, Kang SJ, Choi M, Kim B-H, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer. 2023;23:3–106. https://doi.org/10.5230/jgc.2023.23.e11.

Article  PubMed  PubMed Central  Google Scholar 

Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer Oxf Engl 1990. 2000;36:390–6. https://doi.org/10.1016/s0959-8049(99)00308-1

Cady B, Ramsden DA, Stein A, Haggitt RC. Gastric cancer. Contemporary aspects Am J Surg. 1977;133:423–9. https://doi.org/10.1016/0002-9610(77)90126-x.

Article  CAS  PubMed  Google Scholar 

Bernards N, Creemers GJ, Nieuwenhuijzen GAP, Bosscha K, Pruijt JFM, Lemmens VEPP. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol Off J Eur Soc Med Oncol. 2013;24:3056–60. https://doi.org/10.1093/annonc/mdt401.

Article  CAS  Google Scholar 

Cheon SH, Rha SY, Jeung H-C, Im C-K, Kim SH, Kim HR, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol Off J Eur Soc Med Oncol. 2008;19:1146–53. https://doi.org/10.1093/annonc/mdn026.

Article  CAS  Google Scholar 

Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622–8. https://doi.org/10.1002/ijc.28373.

Article  CAS  PubMed  Google Scholar 

Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21. https://doi.org/10.1016/S1470-2045(08)70035-4.

Article  CAS  PubMed  Google Scholar 

Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2011;14:97–100. https://doi.org/10.1007/s10120-011-0040-6.

Article  Google Scholar 

Tan K-K, Quek TJ-L, Wong N, Li KK, Lim K-H. Emergency surgery for perforated gastric malignancy: an institution’s experience and review of the literature. J Gastrointest Oncol. 2011;2:13–8. https://doi.org/10.3978/j.issn.2078-6891.2011.001

Fujitani K, Yang H-K, Mizusawa J, Kim Y-W, Terashima M, Han S-U, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17:309–18. https://doi.org/10.1016/S1470-2045(15)00553-7.

Article  CAS  PubMed  Google Scholar 

Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, et al. International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1). Ann Gastroenterol Surg. 2022;6:227–40. https://doi.org/10.1002/ags3.12515.

Article  PubMed  Google Scholar 

Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: a review. World J Gastrointest Oncol. 2018;10:398–409. https://doi.org/10.4251/wjgo.v10.i11.398.

Article  PubMed  PubMed Central  Google Scholar 

Alyami M, Bonnot P-E, Mercier F, Laplace N, Villeneuve L, Passot G, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021;47:123–7. https://doi.org/10.1016/j.ejso.2020.05.021.

Article  Google Scholar 

Acs M, Piso P, Glockzin G. Peritoneal metastatic gastric cancer: local treatment options and recommendations. Curr Oncol. 2024;31:1445–59. https://doi.org/10.3390/curroncol31030109.

Article  PubMed  PubMed Central  Google Scholar 

Du R, Hu P, Liu Q, Zhang J. Conversion surgery for unresectable advanced gastric cancer: a systematic review and meta-analysis. Cancer Invest. 2019;37:16–28. https://doi.org/10.1080/07357907.2018.1551898.

Article  PubMed  Google Scholar 

Japanese Gastric Cancer Treatment Guidelines. 6th edition. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2021;2023(26):1–25. https://doi.org/10.1007/s10120-022-01331-8.

Article  Google Scholar 

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000.

Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34. https://doi.org/10.1002/(sici)1097-0258(19981230)17:24%3c2815::aid-sim110%3e3.0.co;2-8.

Article  CAS  PubMed  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https://doi.org/10.1186/1745-6215-8-16.

Article  PubMed  PubMed Central  Google Scholar 

Fang J, Huang X, Chen X, Xu Q, Chai T, Huang L, et al. Efficacy of chemotherapy combined with surgical resection for gastric cancer with synchronous ovarian metastasis: a propensity score matching analysis. Cancer Med. 2023;12:17126–38. https://doi.org/10.1002/cam4.6362.

Article  PubMed  PubMed Central  Google Scholar 

Choe HJ, Kim JW, Han SH, Lee JH, Ahn SH, Park DJ, et al. Conversion surgery in metastatic gastric cancer and cancer dormancy as a prognostic biomarker. Cancers Basel. 2019;12. https://doi.org/10.3390/cancers12010086

Yu P, Ding G, Huang X, Wang C, Fang J, Huang L, et al. Genomic and immune microenvironment features influencing chemoimmunotherapy response in gastric cancer with peritoneal metastasis: a retrospective cohort study. Int J Surg. 2024;110:3504–17. https://doi.org/10.1097/JS9.0000000000001281.

Article  PubMed  PubMed Central  Google Scholar 

Hojo Y, Ishida Y, Tomita T, Kurahashi Y, Nakamura T, Kitayama Y, et al. Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer. Eur J Surg Oncol. 2024;50: 107314. https://doi.org/10.1016/j.ejso.2023.107314.

Article  PubMed  Google Scholar 

Hayano K, Watanabe H, Ryuzaki T, Sawada N, Ohira G, Kano M, et al. Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy. Surg Case Rep. 2020;6:219. https://doi.org/10.1186/s40792-020-00984-w.

Article  PubMed  PubMed Central  Google Scholar 

Nakanishi K, Tanaka C, Kanda M, Miyata K, Furukawa K, Maeda O, et al. Low expectancy of conversion surgery with R0 resection in patients with CEA > 5.0 ng/mL at the initial RECIST evaluation for metastatic gastric cancer. Cancers Basel. 2023;15. https://doi.org/10.3390/cancers15215197

Yamaguchi K, Yoshida K, Tanahashi T, Takahashi T, Matsuhashi N, Tanaka Y, et al. The long-term survival of stage IV gastric cancer patients with conversion therapy. Gastric Cancer. 2018;21:315–23. https://doi.org/10.1007/s10120-017-0738-1.

Article  CAS  PubMed  Google Scholar 

Nie R, Yuan S, Li Y, Chen S, Li S, Yang L, et al. Risk-stratification model to select conversion surgery for advanced gastric cancer patients. Chin J Cancer Res. 2019;31:178–87. https://doi.org/10.21147/j.issn.1000-9604.2019.01.13

Yang Z, Lu S, Shi M, Yuan H, Wang Z, Ni Z, et al. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study. Gastric Cancer. 2024;27:387–99. https://doi.org/10.1007/s10120-023-01452-8.

Article  CAS  PubMed  Google Scholar 

Kim SW. The result of conversion surgery in gastric cancer patients with peritoneal seeding. J Gastric Cancer. 2014;14:266–70. https://doi.org/10.5230/jgc.2014.14.4.266.

Article  PubMed  PubMed Central  Google Scholar 

Ohnuma H, Sato Y, Onoyama N, Hamaguchi K, Hayasaka N, Sato M, et al. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis. J Cancer Res Clin Oncol. 2021;147:2385–96. https://doi.org/10.1007/s00432-021-03516-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canbay E, Canbay Torun B, Cosarcan K, Altunal C, Gurbuz B, Bilgic C, et al. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer. J Gastrointest Oncol. 2021;12:S47–56. https://doi.org/10.21037/jgo-20-121

Yago A, Haruta S, Ueno M, Ogawa Y, Shimoyama H, Ohkura Y, et al. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy. World J Surg Oncol. 2022;20:35. https://doi.org/10.1186/s12957-022-02512-6.

Article